George Kottayil - ACST Old Chief US
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Insider
George Kottayil is Chief US of ACST Old
| Age | 61 |
| Phone | 818-839-4378 |
| Web | https://www.acastipharma.com |
George Kottayil Latest Insider Activity
Tracking and analyzing the buying and selling activities of George Kottayil against ACST Old stock is an integral part of due diligence when investing in ACST Old. George Kottayil insider activity provides valuable insight into whether ACST Old is net buyers or sellers over its current business cycle. Note, ACST Old insiders must abide by specific rules, including filing SEC forms every time they buy or sell ACST Old'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
George Kottayil over a year ago Acasti Pharma exotic insider transaction detected |
ACST Old Management Efficiency
The company has return on total asset (ROA) of (0.1162) % which means that it has lost $0.1162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1856) %, meaning that it created substantial loss on money invested by shareholders. ACST Old's management efficiency ratios could be used to measure how well ACST Old manages its routine affairs as well as how well it operates its assets and liabilities.ACST Old currently holds 11.56 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. ACST Old has a current ratio of 10.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ACST Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Shine | Ocugen Inc | N/A | |
| Victoria Rac | Bio Path Holdings | N/A | |
| Leeds Chow | ABVC Biopharma | 35 | |
| Torsten Hombeck | Akari Therapeutics PLC | 54 | |
| DDS MS | Aditxt Inc | 59 | |
| Jeffery MD | Bio Path Holdings | N/A | |
| Dr DVM | Ibio Inc | 55 | |
| Ian MBA | Jaguar Animal Health | 57 | |
| Mark Newman | GeoVax Labs | 70 | |
| Robert Lutz | Ibio Inc | 55 | |
| Eugene Jiang | ABVC Biopharma | 39 | |
| Matthew Shatzkes | Aditxt Inc | N/A | |
| Annie Mack | Akari Therapeutics PLC | N/A | |
| Amro Albanna | Aditxt Inc | 55 | |
| Thomas CPA | Aditxt Inc | 52 | |
| Alexander Klibanov | Pulmatrix | 75 | |
| MBA MBA | Ocugen Inc | 58 | |
| Vijay Tammara | Ocugen Inc | 64 | |
| MBA MD | Moleculin Biotech | N/A | |
| Zara Gaudioso | Ocugen Inc | N/A | |
| Jacqueline Northcut | Moleculin Biotech | 62 | |
Management Performance
| Return On Equity | -0.19 | |||
| Return On Asset | -0.12 |
ACST Old Leadership Team
Elected by the shareholders, the ACST Old's board of directors comprises two types of representatives: ACST Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ACST. The board's role is to monitor ACST Old's management team and ensure that shareholders' interests are well served. ACST Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ACST Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Kottayil, Chief US | ||
| Robert CPA, Principal Officer | ||
| Prashant Kohli, Chief Officer | ||
| Amresh Kumar, VP Management | ||
| Janelle DAlvise, President CEO | ||
| Yves Lachance, VP Compliance | ||
| Carrie DAndrea, VP Operations | ||
| Pierre MD, COO CoFounder | ||
| Christine Pelletier, Director HR |
ACST Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ACST Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.12 | |||
| Current Valuation | 11.17 M | |||
| Shares Outstanding | 10.14 M | |||
| Shares Owned By Insiders | 38.39 % | |||
| Shares Owned By Institutions | 21.22 % | |||
| Number Of Shares Shorted | 154.19 K | |||
| Price To Earning | 15.34 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 208.39 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in ACST Stock
If you are still planning to invest in ACST Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACST Old's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |